Fluorouracil, Oxaliplatin, and Panitumumab

About

Membership operator: AND

Therapies: 3

Therapies

Fluorouracil (tx:ncit:C505)

Oxaliplatin (tx:ncit:C1181)

Panitumumab (tx:ncit:C1857)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (2) Wild type HRAS, Wild type KRAS Colorectal Adenocarcinoma Fluorouracil, Oxaliplatin, Panitumumab
EMA (1) Wild type KRAS, Wild type NRAS Colorectal Adenocarcinoma Fluorouracil, Oxaliplatin, Panitumumab